ARS Pharmaceuticals Inc. (SPRY)
11.52
0.16 (1.41%)
At close: Jan 15, 2025, 12:39 PM
Price Reaction to Earnings Reports
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov 13, 2024
(Q3) BMC Q3 2024 | 17.49 | 16.61 | 14.08 | 14.51 | 15.25 | 13.99 | 14.11 | 14.01 | 13.78 | 13.79 | 13.38 | 16.14 | ||
IV: 0.65 RSI: 42 SPRY % | 2.64% | -5.03% | -5.03% | 3.05%
| 8.31%
| -0.64%
| 0.21%
| -0.71% | -1.64% | 0.07% | -1.25% | 2.67% | ||
Aug 6, 2024
(Q2) AMC Q2 2024 | 9.90 | 9.32 | 9.78 | 9.68 | 10.27 | 9.45 | 9.57 | 9.89 | 10.88 | 10.85 | 13.00 | 10.87 | ||
IV: 0.76 RSI: 45 SPRY % | -5.62% | -5.86% | -5.86% | -1.02%
| 5.01%
| -3.37%
| -2.15%
| 3.34% | 10.01% | -0.28% | -0.46% | -0.91% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.